AZD5991

Min.Order / FOB Price:Get Latest Price

0	Negotiable

Min.Order :0
Purity: ≥98%

Keywords

AZD-5991 AZD 5991

Quick Details

Appearance:Solid Powder
Application:Antineoplastic Agents
PackAge:
ProductionCapacity:
Storage:Store at -20°C
Transportation:

Superiority:

We provide customized and high-quality AZD5991 product for your project.

Details:

AZD5991 is a potent and selective Mcl-1 inhibitor with an IC50 of <3 nM in FRET assay for treatment of hematologic cancers. AZD5991 has high selectivity and affinity for Mcl-1 and is currently in clinical development. AZD5991 shows potent antitumor activity in vivo with complete tumor regression in several models of multiple myeloma and acute myeloid leukemia after a single tolerated dose as monotherapy or in combination with bortezomib or venetoclax. AZD5991 monotherapy caused apoptosis preferentially in hematological cell lines with 6/22 AML and 7/19 MM cell lines showing caspase EC50 values <100 nM. In solid tumor cell lines single agent activity was seen mostly in NSCLC and BrCa.

View All